| scholarly article | Q13442814 |
| P50 | author | David N. Zacks | Q41891838 |
| P2093 | author name string | Naheed W Khan | |
| John B Miller | |||
| Grant M Comer | |||
| David M Reed | |||
| Victor M Elner | |||
| Eric W Schneider | |||
| P2860 | cites work | Experimental intravitreal gentamicin | Q67823999 |
| Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics | Q69354779 | ||
| Lack of correlation of postmortem vitreous humor calcium concentration with antemortem serum calcium concentration | Q70605560 | ||
| Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study | Q71136890 | ||
| Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group | Q71559401 | ||
| Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study | Q71863618 | ||
| Postmortem Chemistries on Human Vitreous Humor | Q72352810 | ||
| Postmortem Chemistry of the Vitreous Body in Man | Q78845461 | ||
| Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations | Q79493278 | ||
| Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program | Q79972799 | ||
| In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection | Q80193908 | ||
| Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis | Q81229229 | ||
| Incidence of endophthalmitis after 20- and 25-gauge vitrectomy | Q81397833 | ||
| Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening | Q82856339 | ||
| Intraocular fluid dynamics. I. Steady-state concentration gradients of magnesium, potassium and calcium in relation to the sites and mechanisms of ocular cation transport processes | Q93807707 | ||
| Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers | Q24679375 | ||
| Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis | Q28757559 | ||
| Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits | Q30451719 | ||
| National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. | Q30977541 | ||
| Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin | Q31954126 | ||
| Practice styles and preferences of ASCRS members--2003 survey | Q33201873 | ||
| Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India | Q33261667 | ||
| In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains | Q33979251 | ||
| The need for cataract surgery: projections based on lens opacity, visual acuity, and personal concern | Q35306997 | ||
| Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study | Q35311385 | ||
| Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections | Q36076017 | ||
| Acute endophthalmitis following cataract surgery: a systematic review of the literature | Q36121591 | ||
| Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)'s fifth report | Q36142206 | ||
| The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. | Q36161698 | ||
| Effect of protein binding of daptomycin on MIC and antibacterial activity | Q36757414 | ||
| Inhibition of membrane potential-dependent amino acid transport by daptomycin | Q40088405 | ||
| Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model | Q40345387 | ||
| Trends in aging--United States and worldwide. | Q40599470 | ||
| Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania | Q40734214 | ||
| Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates | Q40902642 | ||
| Vancomycin-resistant enterococcal endophthalmitis | Q43023421 | ||
| Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial | Q43541201 | ||
| Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint | Q43753597 | ||
| Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis | Q44043961 | ||
| Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci | Q44227394 | ||
| Bactericidal activity of daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials | Q44299923 | ||
| Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection | Q44372550 | ||
| Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit | Q44713057 | ||
| Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance | Q44727665 | ||
| Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001. | Q46653172 | ||
| Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. | Q46766488 | ||
| Emergence of vancomycin tolerance in Streptococcus pneumoniae | Q47954249 | ||
| Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. | Q54405848 | ||
| The Induction of Meningeal Inflammation by Components of the Pneumococcal Cell Wall | Q57077301 | ||
| In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives | Q61777251 | ||
| P433 | issue | 6 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1199-1206 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Retina | Q15753094 |
| P1476 | title | Intravitreal daptomycin: a safety and efficacy study | |
| P478 | volume | 31 |
| Q87418619 | A case-control study of post-operative endophthalmitis diagnosed at a Spanish hospital over a 13-year-period |
| Q41498849 | Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model |
| Q35941248 | Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics |
| Q53746372 | Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. |
| Q41903003 | Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis |
| Q38350572 | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
| Q40596809 | Safety of intravitreal quinupristin/dalfopristin in an animal model |
| Q38672537 | Staphylococcus aureus and its Bearing on Ophthalmic Disease |
| Q40154254 | Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes |
Search more.